CHAPEL HILL, N.C., July 6, 2018 /PRNewswire/ — Patient adherence has long been a challenge for the pharmaceutical industry.

It is estimated that poor drug adherence costs the healthcare system $300 billion a year and results in 125,000 deaths annually in the United States. The most common drivers behind nonadherence are financial and/or behavioral. It takes effective patient adherence program design and management to overcome these formidable hurdles. 

A new Best Practices, LLC study found that many pharma companies are segmenting patients and customizing content to enhance the results of their adherence programs. In the research study, 80 percent of respondents cited some level of tailoring in their program portfolio, defined by segmentation of patients and subsequent customization of content to fit the segments. “We are tailoring and moving towards personalization by designing programs that can be customized depending on the target customer segments,” said one participant, a vice president of marketing.

Research and consulting leader Best Practices, LLC undertook this research to explore how adherence leaders in pharma are ensuring they have the support and resources to create effective patient adherence programs. The report, “Gaining Support for Patient Adherence Programs and Effective Resource Allocation to Drive Adherence,” provides evidence-based benchmarks to address questions such as:

  • Patient Adherence Program Management – Do you have the right structure to deliver the best program experience to your patients?
  • Adherence Program Staffing and Investment – Are you investing in the right areas with the right budget? Do you need proof points to advocate for more funding?
  • Adherence Program Design – Who are the best agency partners? What is the impact of customizing program content based on patient segments? Which innovations work best?

The study collected insights from 20 respondents in managerial or higher level positions at leading companies with patient adherence programs.

To learn more about this report, download a complimentary report excerpt at For related research, visit our Best Practices, LLC website at

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC’s clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

Cision View original content:

SOURCE Best Practices, LLC

[ Back To’s Homepage ]

Source link


Please enter your comment!
Please enter your name here